<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title><![CDATA[Jiangsu Run'an Pharmaceutical Co. Ltd.]]></title><category><![CDATA[Jiangsu Run'an Pharmaceutical Co. Ltd.]]></category><description><![CDATA[Run'an Pharmaceutical Osagai Farmazeutiko Aktiboa (API), Tarteko Farmazia, Tetrazole eta beste produktu batzuen fabrikatzaile eta hornitzaile esperientziadun bat da. Kontsumitzaileei kalitate-bermea azkar eskain diezaiekegu. Gure fabrikak Txinan egindako kalitate handiko produktuak eskaintzen ditu prezio lehiakorrekin. Ongi etorria zara eskaera egiteko.]]></description><link><![CDATA[https://eu.jsrapharm.com]]></link><language>eu</language><pubDate>4/18/2026 8:19:14 AM</pubDate><lastBuildDate>4/18/2026 8:19:14 AM</lastBuildDate><item><title><![CDATA[2023CPHI Bartzelona]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-647.html]]></link><pubDate><![CDATA[2024-04-22]]></pubDate></item><item><title><![CDATA[Bildu kapitulu berri baterako]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-648.html]]></link><pubDate><![CDATA[2024-04-22]]></pubDate></item><item><title><![CDATA[Bildu indarrak aurrera egin|Jiangsu Runan Pharmaceutical Co.,LTD urteko bilera eta gomendio bilera]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-649.html]]></link><pubDate><![CDATA[2024-04-22]]></pubDate></item><item><title><![CDATA[2024CPHI Japonia]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-650.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[2024an konpainiako logistika sailean gas-isurketen istripuetarako zulagailu praktiko berezia]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-651.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[2023API Erakusketa]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-652.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Hitzaldia Jiangsu Runan Pharmaceutical-en Esperientzia Truke Aurreratuen Konferentzian]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-653.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Prestakuntza praktiko integrala 2023an produkzio-segurtasunaren istripuetarako]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-654.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd-ek 1. klaseko sendagai berritzaileen entsegu klinikoetarako onarpenaren oharra]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-655.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Jiangsu Run'an Pharmaceutical Co., Ltd. Segurtasuneko Produkzioaren Hilabeteko jardueren laburpena, ebaluazioa, sari eta goraipamen oharra]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-656.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Jiangsu Runan Pharmaceutical-ek GMP ikuskapena ongi etorria ematen dio]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-657.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Jabetza intelektualaren babesa indartu eta mendilerro berritzaile bat sortu]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-658.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Chen Zhichang, Udal Alderdi Batzordeko idazkariak, Zhengda Qingjiang Pharmaceutical-eko lantegi berriaren eraikuntzari buruzko ikerketa egin zuen.]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-659.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Jiangsu Run'an Pharmaceutical Co., Ltd.ren iragarpena 2023ko Ekoizpen Garbiaren Auditoria baino lehen]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-660.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Sodio nitroprusia eta urapidil, biak hipertentsiboen aurkako sendagaiak, kontraindikazio eta erreakzio kaltegarri desberdinak dituzte!]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-661.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Dexmedetomidinaren ezaugarri farmakologikoak eta bere aplikazioa ebakuntza osteko eldarnioan adineko pazienteetan]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-662.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Nor da eraginkorragoa, Elamod edo Metotrexato]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-663.html]]></link><pubDate><![CDATA[2024-05-06]]></pubDate></item><item><title><![CDATA[Lifitegrast]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-927.html]]></link><pubDate><![CDATA[2024-06-24]]></pubDate></item><item><title><![CDATA[2024 CPHI TXINA Shangai]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-928.html]]></link><pubDate><![CDATA[2024-07-17]]></pubDate></item><item><title><![CDATA[Difelikefalin-FDAk onartutako lehen sendagaia giltzurruneko gaixotasun kronikoa (CKD)-ekin erlazionatutako pruritoa tratatzeko-Difelikefalin injekzioa]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1597.html]]></link><pubDate><![CDATA[2024-09-21]]></pubDate></item><item><title><![CDATA[5-amino tetrazola da]]></title><link><![CDATA[https://eu.jsrapharm.com/news/is-5-amino-tetrazole-87129.html]]></link><pubDate><![CDATA[2024-09-23]]></pubDate></item><item><title><![CDATA[Zeintzuk dira 1H-tetrazolaren propietateak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1599.html]]></link><pubDate><![CDATA[2024-09-24]]></pubDate></item><item><title><![CDATA[Zeintzuk dira 2,6-Diaminopiridina erabiltzearen albo-ondorioak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1600.html]]></link><pubDate><![CDATA[2024-09-25]]></pubDate></item><item><title><![CDATA[Zein da Gemcitabine HCl T3-ren kostua eta aseguruak estaltzen al du?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1601.html]]></link><pubDate><![CDATA[2024-09-26]]></pubDate></item><item><title><![CDATA[Ba al dago proba klinikorik Gemcitabine HCl T6rako?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1602.html]]></link><pubDate><![CDATA[2024-09-27]]></pubDate></item><item><title><![CDATA[Nola administratzen da Gemcitabine HCl T8 pazienteei?]]></title><link><![CDATA[https://eu.jsrapharm.com/news/how-is-gemcitabine-hcl-t8-administered-to-patients--57448.html]]></link><pubDate><![CDATA[2024-09-30]]></pubDate></item><item><title><![CDATA[Ba al dago Gemcitabine HCl T9 tratamendu alternatiborik minbizi gaixoentzat?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1604.html]]></link><pubDate><![CDATA[2024-10-01]]></pubDate></item><item><title><![CDATA[Zeintzuk dira 4,5-Dicyanoimidazolaren erabilerak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1605.html]]></link><pubDate><![CDATA[2024-10-02]]></pubDate></item><item><title><![CDATA[Zer da azido 4-nitrobenzoikoa eta bere erabilerak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news/what-is-4-nitrobenzoic-acid-and-its-uses--78146.html]]></link><pubDate><![CDATA[2024-10-03]]></pubDate></item><item><title><![CDATA[Zer da Urapidil Klorhidratoa]]></title><link><![CDATA[https://eu.jsrapharm.com/news/what-is-urapidil-hydrochloride-42624.html]]></link><pubDate><![CDATA[2024-10-04]]></pubDate></item><item><title><![CDATA[Nola eragiten dio Dexmedetomidina Hidrokloridoak sistema kardiobaskularrari?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1608.html]]></link><pubDate><![CDATA[2024-10-07]]></pubDate></item><item><title><![CDATA[Zeintzuk dira Rokuronio Bromuroaren albo-ondorioak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1609.html]]></link><pubDate><![CDATA[2024-10-08]]></pubDate></item><item><title><![CDATA[Zeintzuk dira albo-ondorioak]]></title><link><![CDATA[https://eu.jsrapharm.com/news/what-are-the-side-effects-41262.html]]></link><pubDate><![CDATA[2024-10-09]]></pubDate></item><item><title><![CDATA[Zein da gomendatutako dosia]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1611.html]]></link><pubDate><![CDATA[2024-10-10]]></pubDate></item><item><title><![CDATA[Zeintzuk dira Garlicin sartzeko modurik onenak]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1612.html]]></link><pubDate><![CDATA[2024-10-11]]></pubDate></item><item><title><![CDATA[Tetrazolaren abantailak]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1613.html]]></link><pubDate><![CDATA[2024-10-26]]></pubDate></item><item><title><![CDATA[2024 API XI'AN]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1991.html]]></link><pubDate><![CDATA[2024-12-19]]></pubDate></item><item><title><![CDATA[Zergatik da azido benzoikoa baino azido indartsuagoa 4-nitrobenzoiko azido azido sendoagoa?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1993.html]]></link><pubDate><![CDATA[2025-02-13]]></pubDate></item><item><title><![CDATA[Zergatik da 2,6 diaminopiridina funtsezko konposatua sintesi kimikoan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1995.html]]></link><pubDate><![CDATA[2025-02-26]]></pubDate></item><item><title><![CDATA[Zer dira konposatu heteroziklikoak eta zergatik dira garrantzitsuak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1997.html]]></link><pubDate><![CDATA[2025-03-14]]></pubDate></item><item><title><![CDATA[Zenbat dakizu heteroziklei buruz?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-1999.html]]></link><pubDate><![CDATA[2025-03-17]]></pubDate></item><item><title><![CDATA[Nola erabiltzen da 4-nitrobenzoiko azido industrial eta farmazeutikoetan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2184.html]]></link><pubDate><![CDATA[2025-03-24]]></pubDate></item><item><title><![CDATA[Zein da Piridinaren funtzioa?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2185.html]]></link><pubDate><![CDATA[2025-04-02]]></pubDate></item><item><title><![CDATA[Zer arreta jarri behar zaio 2,6 diaminopiridinaren erabileran?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2186.html]]></link><pubDate><![CDATA[2025-04-07]]></pubDate></item><item><title><![CDATA[Nola arindu daiteke Piridina zure produkzioa farmaziak eta produktu kimiko finetan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2187.html]]></link><pubDate><![CDATA[2025-04-10]]></pubDate></item><item><title><![CDATA[Zer da imidazole?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2718.html]]></link><pubDate><![CDATA[2025-04-11]]></pubDate></item><item><title><![CDATA[Zeintzuk dira imidazolaren aplikazio-arloak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2723.html]]></link><pubDate><![CDATA[2025-04-17]]></pubDate></item><item><title><![CDATA[Zein dira gaur egun piridinaren erabilera industrial nagusiak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2747.html]]></link><pubDate><![CDATA[2025-04-18]]></pubDate></item><item><title><![CDATA[Non erabiltzen da tetrazola batez ere?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2768.html]]></link><pubDate><![CDATA[2025-04-24]]></pubDate></item><item><title><![CDATA[Badakizu Dielyl Trisulfide?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2788.html]]></link><pubDate><![CDATA[2025-04-28]]></pubDate></item><item><title><![CDATA[Ba al dago Gemcitabine HCl T9-ren bigarren mailako efektuak?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2793.html]]></link><pubDate><![CDATA[2025-05-20]]></pubDate></item><item><title><![CDATA[Zer balio ordezkaezina da 141-86-6 kasutan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2797.html]]></link><pubDate><![CDATA[2025-05-22]]></pubDate></item><item><title><![CDATA[Zergatik dira ospea lortzen duten DCIren gehigarriak bateriaren fabrikatzaileen artean?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2805.html]]></link><pubDate><![CDATA[2025-06-19]]></pubDate></item><item><title><![CDATA[Zertarako erabiltzen da imidazole-4,5 dicarbonitrile?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2808.html]]></link><pubDate><![CDATA[2025-07-02]]></pubDate></item><item><title><![CDATA[Piridina ezaguna al da kartzinogeno ezaguna?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2812.html]]></link><pubDate><![CDATA[2025-07-11]]></pubDate></item><item><title><![CDATA[Gemcitabine T3: tumorearen tratamenduaren arloan zuzendutako potentzial zehatza erakusten duen droga]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2814.html]]></link><pubDate><![CDATA[2025-07-31]]></pubDate></item><item><title><![CDATA[Tofacitinib citrate erabilera eta ekintza mekanismoa]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2818.html]]></link><pubDate><![CDATA[2025-08-12]]></pubDate></item><item><title><![CDATA[Zergatik aukeratu 4 nitrobenzoiko azido]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2825.html]]></link><pubDate><![CDATA[2025-08-27]]></pubDate></item><item><title><![CDATA[DexmeDetomidine Hydrokloruroaren aplikazio klinikoetan egindako azken aurrerapenak]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2971.html]]></link><pubDate><![CDATA[2025-09-05]]></pubDate></item><item><title><![CDATA[Artritis Iguratimod-ek benetan alda al dezake artritis kronikoa duten gaixoen ikuspegia?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-2985.html]]></link><pubDate><![CDATA[2025-09-09]]></pubDate></item><item><title><![CDATA[Zerk egiten du Apripilast APIak aukera fidagarria farmazia fabrikazioan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3042.html]]></link><pubDate><![CDATA[2025-09-11]]></pubDate></item><item><title><![CDATA[Zerk egiten du CAS-ek 611-75-6 funtsezkoak funtsezkoak diren aplikazio modernoetan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3092.html]]></link><pubDate><![CDATA[2025-09-17]]></pubDate></item><item><title><![CDATA[Zerk egiten du tofacitinib citrate farmazia aukera fidagarria?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3143.html]]></link><pubDate><![CDATA[2025-09-18]]></pubDate></item><item><title><![CDATA[Zergatik aukeratu DexmeDetomidine Hidrokloruroa aplikazio kliniko eta farmazeutikoetarako?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3266.html]]></link><pubDate><![CDATA[2025-09-23]]></pubDate></item><item><title><![CDATA[Zergatik jotzen da Dielyl Trisulfide konposatu bioaktibo indartsu bat?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3279.html]]></link><pubDate><![CDATA[2025-09-25]]></pubDate></item><item><title><![CDATA[Zergatik aukeratu behar duzu 4-nitrobenzoiko azido zure behar industrial eta farmazietarako?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3290.html]]></link><pubDate><![CDATA[2025-09-28]]></pubDate></item><item><title><![CDATA[Zerk egiten du CAS-ek 540737-29-9 funtsezko bitarteko farmazia sintesian?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3343.html]]></link><pubDate><![CDATA[2025-10-10]]></pubDate></item><item><title><![CDATA[Zergatik da hain garrantzitsua CAS 64887-14-5 aplikazio farmazeutiko modernoetan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3392.html]]></link><pubDate><![CDATA[2025-10-15]]></pubDate></item><item><title><![CDATA[Zer da CAS ZK. 288-94-8 eta zergatik kontuan hartu behar duzu?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3479.html]]></link><pubDate><![CDATA[2025-10-21]]></pubDate></item><item><title><![CDATA[Zergatik bihurtzen ari da Diallyl Trisulfuroa aplikazio kimiko modernoetan funtsezko konposatu bat?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3488.html]]></link><pubDate><![CDATA[2025-11-14]]></pubDate></item><item><title><![CDATA[Nola eragiten du 1H-tetrazolak aplikazio farmazeutikoetan?]]></title><link><![CDATA[https://eu.jsrapharm.com/news-show-3542.html]]></link><pubDate><![CDATA[2026-01-30]]></pubDate></item></channel></rss>